고신대학교복음병원

연구 경력

저서

[저서]
유방암 환자를 위한 치료 안내서 8판

[학술발표]
2025.7 – Optimizing Adjuvant Endocrine Therapy in Premenopausal Women with Early Breast Cancer, LUCID BOOST symposium
2025.6 - The efficacy of Letrozole in the Neoadjuvant Setting a Clinical review and Research proposal, A Beautiful Journey together symposium
2025.5 - Neoadjuvant and Adjuvant systemic therapy in breast cancer, 2025 대한외과학회 춘계학술대회 
2025.4 - Robotic Nipple Sparing Mastectomy Using da Vinci SP, Master video session, KSERS 2025
2025.4 - Evaluation of Combined cfDNA and CA15-3 Change Rates as Predictive Biomarkers for Treatment Response in Metastatic Breast Cancer: A Prospective Study, GBCC 2025
2025.2 – Evaluation of Treatment Response in Metastatic Breast Cancer Using Quantitative cfDNA analysis, APBCS 2025
2024.12 - Development of AI-Based Medical Devices for Early Detection of Breast Cancer, Digital Health Global Symposium, Future Medicine Research Center, Kosin University
2024.11 - Quality of Life According to Surgical Methods in Breast Cancer, Korean Breast Cancer Society (KBCS) Survivorship Research Group
2024.11 – Push the Paradigm in HER2 expressing Breast Cancer, LeadHER Webina, Astrazeneca
2024.8 – Management of Benign Breast Disease, School of Breast, KBCS 
2024.6 – Evolving The New Practice in Dx in mBC, Satellite symposium in 2024 Busan Breast Forum(Daiichi-Sankyo Korea) 
2024.3 – Treatment of Rare Histology in Breast Cancer, Chemotherapy Symposium of Korea Breast Cancer Society(KBCS)
2023.11 – Surgical Therapy for Elderly Patients, Annual Congress of Korea Surgical Society(ACKSS)
2023.10 - The Correlation between Somatic Mutations Identified by Next-Generation Sequencing and Prognosis in Early-Stage Breast Cancer Patients, European Society of Surgical Oncology
2023.7 – Factors to Consider When Making Decisions about Breast Cancer Surgery, Korean Breast Cancer Society (KBCS) Survivorship Research Group
2023.5 – Breast Cancer Systemic Treatment: Current Trends, Kosin Surgery Symposium
2022.11 – Current Standards and Future Perspective of the Management HR+/HER2- Early Breast Cancer, Dionysus Symposium
2022.11 – Early Experience of Stereotactic Vacuum Assisted Breast Biopsy, 2022
2022.10 – Optimal Management and Duration in Low ER Breast Cancer, 2022 Korean Breast Cancer Society
2022.8 – Working on Treatment Adherence in Neratinib, BIXNK Symposium
2022.7 – Early Experience of Stereotactic Vacuum Assisted Breast Biopsy, Newlasta BTS Symposium
2022.4 – Benign Breast Disease (유방양성질환), MBC 부산 TV 닥터 인사이드
2021.11 – Planning Adjuvant Endocrine Therapy HR+/HER2- EBC, VICTORY Symposium
2021.6 – Health Insurance Coverage for Breast Ultrasound, Busan Society of Surgery
2021.5 – Breast Cancer Gene Analysis Through Next Generation Sequencing, 2021 Annual Congress Korean Surgical Society
2019.10 – Clinical Pathologic Association with Breast Cancer Gene Analysis Through Next Generation Sequencing, 12th Scientific Meeting, ASBD
2019.4 – Anti-Hormone Monotherapy in Breast Cancer Patients Younger Than 50 Years: N1 Stage, Hormone Receptor Positive and HER2-Negative, 2019 GBCC
2019.4 – Oncoplastic Round Block Technique of Breast Conservation Surgery, 2019 GBCC
2019.4 – Somatic Mutation in Breast Cancer Through Next Generation Sequencing, 2019 GBCC
2018.10 – Anti-Hormonal Therapy Alone in N1 Stage Breast Cancer Patients With Hormone Receptor Positive and HER2-Negative, 2018 MIBC, 4th CoBrCa

[주요논문 : 이외 다수]
Impact of Tumor Location on Aesthetic Outcomes in Oncoplastic Breast-Conserving Surgery: A Retrospective Comparison of Three Acellular Dermal Matrix Techniques, Hyung-Suk Y, HanGwak, Jin-Hyung Park, Sung Ui Jung, Jin-Hyuk Choi and Yoon-Soo Kim. Cancers 2025, 17, 1293

Treatment Approach for Rare Histologic Subtypes of Breast Cancer: A Review, Sung Ui Jung, M.D. , J Breast Dis 2024 December; 12(2): 23-32

Clinical Outcomes in Patients With DLBCL Treated With R-CHOP According to Radiotherapy and Interim PET Response, JESANG YU , SUNG UI JUNG, JIN HYUK CHOI, SUNGMIN JUN, HO SUP LEE and DAJUNG KIM, CANCERDIAGNOSIS &PROGNOSIS 4: 172-181 (2024)

Intensive Surveillance for Women With Breast Cancer: A Multicenter Retrospective Study in Korea, Sungmin Park, Hyeong-Gon Moon, Jong Won Lee, Ku Sang Kim,  Zisun Kim, So-Youn Jung, Jihyoun Lee, Se Kyung Lee,  Byung Joo Chae, Sung Ui Jung, Jung Whan Chun, Jong-Ho Cheun, Hyun Jo Youn, J Breast Cancer. 2024 Aug;27(4):235-247

Prognostic significance of TP53 and PIK3CA mutations analyzed by next-generation sequencing in breast cancer, Jin Hyuk Choi, MD, Jesang Yu, MD, PhD, Minjung Jung, MD, PhD, Junyong Jekal, MD, Ku Sang Kim, MD, Sung Ui Jung, MD, Medicine (Baltimore) 2023 Sep 22;102(38):e35267 

Application of Raman spectroscopy in breast cancer surgery, Yikeun Kim1, Sung Ui Jung2, Jinhyuk Choi, Kosin Medical Journal 2023;38(3):176-183

“Tear-Drop Appearance" Wrap: A Novel Implant Coverage Method for Creating Natural Contour in Prepectoral Prosthetic-Based Breast Reconstruction.Kim HI, Kim BS, Park JH, Yi HS, Kim HY, Choi JH, Jung SU, Kim YS. , J. Clin. Med. 2022

The effects of poloxamer and sodium alginate mixture (Guardix-SG®) on range of motion after axillary lymph node dissection: A single-center, prospective, randomized, double-blind pilot study.Lee SB, Gwark SC, Kang CM, Sohn G, Kim J, Chung IY, Lee JW, Kim HJ, Ko BS, Ahn SH, Kim W, Do J, Jeon JY, Kim J, Um E, Yoon TI, Jung SU, Han M, Son BH. PLoS One. 2020 Sep 23;15(9):e0238284. 

Long-term survival with eribulin monotherapy after whole brain radiation therapy in a patient with brain metastasis from breast cancer. Jung SU, Jeon CW, Choi JH.Asian J Surg. 2020 Oct;43(10):1008-1009. 

Retrospective review of 108 breast reconstructions using the round block technique after breast-conserving surgery: Indications, complications, and outcomes. In SK, Kim YS, Kim HS, Park JH, Kim HI, Yi HS, Park JC, Jeon CW, Choi JH, Jung SU, Kim HY. Arch Plast Surg. 2020 Nov;47(6):574-582.

Pathological complete response to neoadjuvant trastuzumab and pertuzumab therapy is related to human epidermal growth factor receptor 2 (HER2) amplification level in HER2-amplified breast cancer. Choi JH, Jeon CW, Kim YO, Jung SU. Medicine (Baltimore). 2020 Nov 13;99(46):e23053. 

Palbociclib with letrozole as second-line neo-systemic therapy after failure of neo-adjuvant chemotherapy for luminal type breast cancer: A case report. Jung SU, Jung M, Choi JH, Jeon CW.Medicine (Baltimore). 2021 Apr 9;100(14):e25175.

Survival outcome of adjuvant endocrine therapy alone for patients with lymph node-positive, hormone-responsive, HER2-negative breast cancer. Jung SU, Sohn G, Kim J, Chung IY, Lee JW, Kim HJ, Ko BS, Son BH, Ahn SH, Yang SW, Lee SB. Asian J Surg. 2019 Oct;42(10):914-921. 

Review of 107 Oncoplastic Surgeries Using an Acellular Dermal Matrix with the Round Block Technique, HI, Kim BS, Kim YS, Yi HS, Park JH, Choi JH, Jung SU, Kim HY. J Clin Med. 2022 May 26;11(11):3005.
 

[방송출연]
[닥터스] 생존을 넘어 행복으로 유방암 수술과 재건